SDHI Fungicides

SDHI Fungicides

Global SDHI Fungicides Market to Reach US$5.1 Billion by 2030

The global market for SDHI Fungicides estimated at US$2.9 Billion in the year 2023, is expected to reach US$5.1 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2023-2030. Boscalid, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Fluopyram segment is estimated at 9.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$712.4 Million While China is Forecast to Grow at 8.7% CAGR

The SDHI Fungicides market in the U.S. is estimated at US$712.4 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$550.3 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.4% and 9.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.3% CAGR.

Global SDHI Fungicides Market - Key Trends and Drivers Summarized

SDHI (succinate dehydrogenase inhibitor) fungicides are a class of chemical agents that target the succinate dehydrogenase enzyme complex, which is crucial for energy production in fungal cells. By inhibiting this enzyme, SDHI fungicides disrupt the cellular respiration process within fungi, effectively preventing their growth and spread. This class of fungicides has become increasingly popular in the agricultural sector due to its effectiveness against a broad spectrum of fungal diseases that affect crops such as wheat, barley, fruits, and vegetables. The chemical versatility of SDHIs allows them to be used in various formulations and application methods, making them a versatile tool in integrated pest management (IPM) programs.

The adoption of SDHI fungicides has been driven by their high efficacy and the growing need for more sustainable crop protection practices. As traditional fungicides become less effective due to resistance issues, SDHIs offer an alternative with a different mode of action. This is particularly important in managing diseases that have developed resistance to other fungicide classes, such as strobilurins and triazoles. Moreover, the integration of SDHI fungicides into crop protection regimes helps in extending the lifecycle of existing fungicidal solutions by reducing the overall selection pressure on fungal populations. Agricultural producers and researchers are also focusing on combining SDHIs with other fungicidal agents to enhance disease control and delay resistance development, which is critical for maintaining high levels of crop productivity.

The growth in the SDHI fungicide market is driven by several factors, including technological advancements in fungicide formulations, increasing pressure from global food demand, and stricter environmental regulations. Enhanced formulation technology has improved the efficacy and environmental profile of SDHI fungicides, making them more appealing to both conventional and sustainable agriculture operations. The intensifying need to boost crop yields to feed a growing global population has spurred the adoption of effective and reliable fungal disease management solutions. Furthermore, regulatory bodies are increasingly scrutinizing agricultural inputs, leading to a shift towards fungicides with lower ecotoxicological impacts. These trends, coupled with ongoing research into the development of novel SDHI compounds with broader spectrums of activity and reduced resistance risks, are key drivers propelling the expansion of this market.

Select Competitors (Total 22 Featured) -

• Bayer AG
• FMC Corporation
• Nissan Chemical Corporation
• Bayer AG - Crop Science Division
• Ishihara Sangyo Kaisha Ltd.
• UPL Ltd.
• ADAMA Agricultural Solutions Limited
• Nihon Nohyaku Co., Ltd.
• Valent U.S.A. Corporation
• Corteva Agriscience ¢
• Anhui Fengle Agrochemical Co., Ltd.
• Jingbo Agrochemicals Technology Co., Ltd.
• Koppert Biological Systems India Pvt., Ltd.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.